- Stocks
- Healthcare
- NYSE: BSX

Price (delayed)

$37.03

Market cap

$53.02B

P/E Ratio

13.97

Dividend/share

N/A

EPS

$2.65

Enterprise value

$60.34B

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology,

BSX's quick ratio has surged by 124% year-on-year and by 8% since the previous quarter

The equity has soared by 60% YoY

The P/E is 85% below the 5-year quarterly average of 96.0 but 10% above the last 4 quarters average of 12.7

Boston Scientific's gross profit has decreased by 8% YoY and by 2% QoQ

The EPS has decreased by 7% from the previous quarter

What are the main financial stats of BSX

Market
Valuations
Earnings

Shares outstanding

1.43B

Market cap

$53.02B

Enterprise value

$60.34B

Price to earnings (P/E)

13.97

Price to book (P/B)

3.4

Price to sales (P/S)

5.24

EV/EBIT

1,138.45

EV/EBITDA

56.71

EV/Sales

5.97

Revenue

$10.11B

EBIT

$53M

EBITDA

$1.06B

Free cash flow

$1.25B

Per share
Balance sheet
Liquidity

EPS

$2.65

Free cash flow per share

$0.87

Book value per share

$10.88

Revenue per share

$7.06

TBVPS

$9.72

Total assets

$30.85B

Total liabilities

$15.28B

Debt

$9.34B

Equity

$15.56B

Working capital

$2.86B

Debt to equity

0.6

Current ratio

1.87

Quick ratio

1.1

Net debt/EBITDA

6.87

Margins
Efficiency
Dividend

EBITDA margin

10.5%

Gross margin

67.2%

Net margin

36.6%

Operating margin

0.8%

Return on assets

12%

Return on equity

25%

Return on invested capital

0.3%

Return on capital employed

0.2%

Return on sales

0.5%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Boston Scientific stock price performed over time

Intraday

-1.31%

1 week

1.93%

1 month

7.77%

1 year

-15.94%

YTD

3%

QTD

3%

How have Boston Scientific's revenue and profit performed over time

Revenue

$10.11B

Gross profit

$6.79B

Operating income

$80M

Net income

$3.7B

Gross margin

67.2%

Net margin

36.6%

Boston Scientific's operating income has plunged by 95% YoY and by 88% from the previous quarter

BSX's operating margin has dropped by 95% year-on-year and by 88% since the previous quarter

Boston Scientific's gross profit has decreased by 8% YoY and by 2% QoQ

Boston Scientific's net income has decreased by 7% QoQ

What is Boston Scientific's growth rate over time

What is Boston Scientific stock price valuation

P/E

13.97

P/B

3.4

P/S

5.24

EV/EBIT

1,138.45

EV/EBITDA

56.71

EV/Sales

5.97

The P/E is 85% below the 5-year quarterly average of 96.0 but 10% above the last 4 quarters average of 12.7

The EPS has decreased by 7% from the previous quarter

The equity has soared by 60% YoY

The stock's price to book (P/B) is 32% less than its 5-year quarterly average of 5.0 and 6% less than its last 4 quarters average of 3.6

BSX's P/S is 14% above its 5-year quarterly average of 4.6 and 2.7% above its last 4 quarters average of 5.1

The revenue has decreased by 2.7% YoY

How efficient is Boston Scientific business performance

The return on assets has surged by 167% year-on-year but it has declined by 11% since the previous quarter

The return on equity has surged by 112% year-on-year but it has declined by 17% since the previous quarter

BSX's ROIC has plunged by 97% YoY and by 86% from the previous quarter

The ROS has plunged by 96% YoY and by 86% from the previous quarter

What is BSX's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for BSX.

How did Boston Scientific financials performed over time

Boston Scientific's total assets is 102% more than its total liabilities

BSX's quick ratio has surged by 124% year-on-year and by 8% since the previous quarter

Boston Scientific's debt is 40% lower than its equity

Boston Scientific's debt has decreased by 14% YoY and by 2.1% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.